Expanding the Future of Healthcare Distribution.
Leveraging three decades of distribution trust and ₹180+ Crore scale to build future C&F warehousing depots, international formulation export channels, and specialized therapeutic delivery.
Proactive Infrastructure Investments Under Active Development
The initiatives detailed below represent future growth and strategic development projects actively planned and underway at CMS Group, advancing our core pharmaceutical wholesale capabilities.
Three Strategic Pillars Shaping Our Tomorrow.
Clear developmental roadmaps structured around expanding infrastructure, international trade compliance, and clinical therapeutic access.
Carrying & Forwarding (C&F Operations)
Dedicated Enterprise Depots for Pharmaceutical Principals
CMS Group is actively developing specialized warehousing infrastructure, temperature-validated storage, and multi-tier logistics capabilities tailored for future Carrying & Forwarding (C&F) operations serving premier pharmaceutical manufacturers across India.
Strategic Milestones & Focus Areas
Pharmaceutical Export
Taking Indian Healthcare Excellence to Global Markets
Building regulatory-compliant export channels with the clear objective of supplying high-quality Indian pharmaceutical formulations to international healthcare markets, adhering to international drug regulatory guidelines.
Strategic Milestones & Focus Areas
Generic & Specialty Distribution
Expanding Access to Affordable & Critical Therapies
Expanding distribution capabilities for high-quality affordable generic medicines as well as complex specialty therapeutic segments including oncology, critical care, nephrology, and immunology.
Strategic Milestones & Focus Areas
From a Strong Legacy to a Larger Healthcare Future.
With foundations built in 1991, ₹180+ Crore consolidated turnover, and pan-India reach, CMS Group is positioned to accelerate modern pharmaceutical distribution and bring vital treatments closer to millions.